Goldman Sachs’s SeaStar Medical ICU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,320
Closed -$5.57K 6718
2025
Q4
$5.57K Buy
2,320
+421
+22% +$1.86K ﹤0.01% 6380
2025
Q3
$10.8K Buy
1,899
+657
+53% +$5.06K ﹤0.01% 6254
2025
Q2
$5.29K Buy
1,242
+222
+22% +$2.56K ﹤0.01% 6018
2025
Q1
$16.9K Sell
1,020
-7
-0.7% -$132 ﹤0.01% 5949
2024
Q4
$19.9K Buy
+1,027
New +$29.3K ﹤0.01% 5898
2024
Q2
Sell
-42
Closed -$7.75K 5775
2024
Q1
$7.75K Buy
42
+1
+2% +$196 ﹤0.01% 5440
2023
Q4
$4.54K Hold
41
﹤0.01% 5526
2023
Q3
$2.7K Hold
41
﹤0.01% 5466
2023
Q2
$5.29K Hold
41
﹤0.01% 5625
2023
Q1
$18.9K Sell
41
-1
-2% -$851 ﹤0.01% 5673
2022
Q4
$42.9K Buy
42
+1
+2% +$1.62K ﹤0.01% 5616
2022
Q3
$104K Sell
41
-805
-95% -$2.06M ﹤0.01% 5678
2022
Q2
$2.15M Hold
846
﹤0.01% 3986
2022
Q1
$2.14M Hold
846
﹤0.01% 4204
2021
Q4
$2.12M Hold
846
﹤0.01% 4192
2021
Q3
$2.12M Hold
846
﹤0.01% 4149
2021
Q2
$2.1M Hold
846
﹤0.01% 4159
2021
Q1
$2.07M Buy
+846
New +$2.07M ﹤0.01% 3941

Other funds holding ICU

Goldman Sachs's ICU Position: Q1 2026 in Review

Goldman Sachs sold out of SeaStar Medical (ICU) in Q1 2026, closing a stake of 2,320 shares — an estimated $5.57K sold.

Goldman Sachs first reported a position in ICU in Q1 2021 and held it in 18 quarters. The position peaked at $2.15M in Q2 2022. 17 funds tracked by Wall St. Rank hold ICU as of Q1 2026.

  • Goldman Sachs reported no remaining SeaStar Medical position as of Q1 2026 after selling out during the quarter.
  • Goldman Sachs sold 2,320 SeaStar Medical shares in Q1 2026, an estimated $5.57K.
  • Goldman Sachs first reported a position in SeaStar Medical in Q1 2021 and held it in 18 quarters.
  • Goldman Sachs's SeaStar Medical position peaked at $2.15M in Q2 2022.
  • 17 funds tracked by Wall St. Rank held SeaStar Medical as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.